Prognostic Value of the Physical Examination in Patients With Heart Failure and Atrial Fibrillation. Insights From the AF-CHF Trial (Atrial Fibrillation and Chronic Heart Failure)

JACC: Heart Failure

Volumn 2, Issue 1, 2014, Pages 15-23

  Caldentey, Guillem ^a   Khairy, Paul ^a   Roy, Denis ^a   Leduc, Hugues ^a   Talajic, Mario ^a   Racine, Normand ^a   White, Michel ^a   O'Meara, Eileen ^a   Guertin, Marie Claude ^a   Rouleau, Jean L ^a   Ducharme, Anique ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Atrial fibrillation; Heart failure; Outcomes; Physical examination

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; BISOPROLOL; CARVEDILOL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; METOPROLOL; SPIRONOLACTONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CRACKLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART SOUND; HUMAN; JUGULAR VENOUS DISTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THIRD HEART SOUND; VEIN DISEASE; ATRIAL FIBRILLATION; CHRONIC DISEASE; CLINICAL TRIAL; MORTALITY; MULTICENTER STUDY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; ABNORMAL RESPIRATORY SOUND; HEART DEATH;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; MALE; PHYSICAL EXAMINATION; PROGNOSIS;

EID: 84892992720     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.10.004     Document Type: Article

References (39)

1. The SOLVD Investigattors. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. NEngl J Med 1991, 325:293-302.
2. The SOLVD Investigattors. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. NEngl J Med 1992, 327:685-691.
3. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H., Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-786.
4. Solomon S.D., Anavekar N., Skali H., et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005, 112:3738-3744.
5. Pinamonti B., Di Lenarda A., Sinagra G., Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography: clinical, echocardiographic and hemodynamic correlations and prognostic implications. Heart Muscle Disease Study Group. JAm Coll Cardiol 1993, 22:808-815.
6. de Groote P., Millaire A., Foucher-Hossein C., et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. JAm Coll Cardiol 1998, 32:948-954.
7. Tabrizi F., Englund A., Rosenqvist M., Wallentin L., Stenestrand U. Influence of left bundle branch block on long-term mortality in a population with heart failure. Eur Heart J 2007, 28:2449-2455.
8. Lee W.H., Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986, 73:257-267.
9. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. NEngl J Med 1984, 311:819-823.
10. La Vecchia L., Mezzena G., Zanolla L., et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. JHeart Lung Transplant 2000, 19:644-652.
11. Kubánek M., Goode K.M., Lánská V., Clark A.L., Cleland J.G. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2009, 11:367-377.
12. Schlendorf K.H., Kasper E.K. Use of novel and conventional biomarkers for management of patients with heart failure. Curr Treat Options Cardiovasc Med 2011, 13:475-488.
13. Fletcher R.H., Fletcher S.W. Has medicine outgrown physical diagnosis?. Ann Intern Med 1992, 117:786-787.
14. St Clair E.W., Oddone E.Z., Waugh R.A., Corey G.R., Feussner J.R. Assessing housestaff diagnostic skills using a cardiology patient simulator. Ann Intern Med 1992, 117:751-756.
15. Roy D., Talajic M., Nattel S., et al. Rhythm control versus rate control for atrial fibrillation and heart failure. NEngl J Med 2008, 358:2667-2677.
16. Drazner M.H., Hellkamp A.S., Leier C.V., et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ Heart Fail 2008, 1:170-177.
17. Nohria A., Tsang S.W., Fang J.C., et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. JAm Coll Cardiol 2003, 41:1797-1804.
18. Campana C., Gavazzi A., Berzuini C., et al. Predictors of prognosis in patients awaiting heart transplantation. JHeart Lung Transplant 1993, 12:756-765.
19. Lucas C., Johnson W., Hamilton M.A., et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000, 140:840-847.
20. Dunlay S.M., Gheorghiade M., Reid K.J., et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail 2010, 12:367-374.
21. Ambrosy A.P., Pang P.S., Khan S., et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 2013, 34:835-843.
22. Drazner M.H., Rame J.E., Stevenson L.W., Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. NEngl J Med 2001, 345:574-581.
23. Brophy J.M., Dagenais G.R., McSherry F., Willford W., Yusuf S. Amultivariate model for predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 2004, 116:300-304.
24. Damy T., Kalivikbacka-Bennett A., Zhang J., et al. Does the physical examination still have a role in patients with suspected heart failure?. Eur J Heart Fail 2011, 13:1340-1348.
25. Damman K., Voors A.A., Hillege H.L., et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail 2010, 12:974-982.
26. Damman K., van Deursen V.M., Navis G., et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. JAm Coll Cardiol 2009, 53:582-588.
27. Mullens W., Abrahams Z., Francis G.S., et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. JAm Coll Cardiol 2009, 53:589-596.
28. Bock J.S., Gottlieb S.S. Cardiorenal syndrome: new perspectives. Circulation 2010, 121:2592-2600.
29. Stein J.H., Neumann A., Marcus R.H. Comparison of estimates of right atrial pressure by physical examination and echocardiography in patients with congestive heart failure and reasons for discrepancies. Am J Cardiol 1997, 80:1615-1618.
30. Aaronson K.D., Schwartz J.S., Chen T.M., Wong K.L., Goin J.E., Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660-2667.
31. Beck da Silva L., Mielniczuk L., Laberge M., et al. Persistent orthopnea and the prognosis of patients in the heart failure clinic. Congest Heart Fail 2004, 10:177-180.
32. Azevedo E.R., Newton G.E., Floras J.S., Parker J.D. Reducing cardiac filling pressure lowers norepinephrine spillover in patients with chronic heart failure. Circulation 2000, 101:2053-2059.
33. Guazzi M., Arena R. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 2010, 7:648-659.
34. Tribouilloy C.M., Enriquez-Sarano M., Mohty D., et al. Pathophysiologic determinants of third heart sounds: a prospectiveclinical and Doppler echocardiographic study. Am J Med 2001, 111:96-102.
35. Shah S.J., Marcus G.M., Gerber I.L., et al. Physiology of the third heart sound: novel insights from tissue Doppler imaging. JAm Soc Echocardiogr 2008, 21:394-400.
36. Ishmail A.A., Wing S., Ferguson J., Hutchinson T.A., Magder S., Fiegel K.M. Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest 1987, 91:870-873.
37. Westman E.C., Matchar D.B., Samsa G.P., Mulrow C.D., Waugh R.A., Feussner J.R. Accuracy and reliability of apical S3 gallop detection. JGen Intern Med 1995, 10:455-457.
38. Lok C.E., Morgan C.D., Ranganathan N. The accuracy and interobserver agreement in detecting the 'gallop sounds' by cardiac auscultation. Chest 1998, 114:1283-1288.
39. Stevenson L.W., Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989, 261:884-888.